SHR-1210 Alone or in Combination With Decitabine in Relapsed or Refractory Hodgkin Lymphoma
Clinical trial NCT03250962 · UNKNOWN
Trial details
- NCT number
- NCT03250962
- Sponsor
- Chinese PLA General Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-11
- Primary completion
- 2022-07-21
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.